To determine if HER3 inhibitor TX1-85-1 may increase DDP sensitivity in ovarian cancer cells, a drug combination test of TX1-85-1 and DDP in A2780-DDP cells was performed. This evidence concerns the gene ERBB3 and ovarian carcinoma.